Toscano Marco, De Grandi Roberta, Miniello Vito Leonardo, Mattina Roberto, Drago Lorenzo
Laboratory of Technical Sciences for Laboratory Medicine, Department of Biomedical Science for Health, University of Milan, Milan, Italy.
Department of Paediatrics, Aldo Moro University of Bari-Giovanni XXIII Hospital, Bari, Italy.
Dig Liver Dis. 2017 Mar;49(3):261-267. doi: 10.1016/j.dld.2016.11.011. Epub 2016 Dec 6.
Probiotics have been observed to positively influence the host's health, but to date few data about the ability of probiotics to modify the gut microbiota composition exist.
To evaluate the ability of Lactobacillus kefiri LKF01 DSM32079 (LKEF) to colonize the intestinal environment of healthy subjects and modify the gut microbiota composition.
Twenty Italian healthy volunteers were randomized in pre-prandial and post-prandial groups. Changes in the gut microbiota composition were detected by using a Next Generation Sequencing technology (Ion Torrent Personal Genome Machine).
L. kefiri was recovered in the feces of all volunteers after one month of probiotic administration, while it was detected only in three subjects belonging to the pre-prandial group and in two subjects belonging to the post-prandial group one month after the end of probiotic consumption. After one month of probiotic oral intake we observed a reduction of Bilophila, Butyricicomonas, Flavonifractor, Oscillibacter and Prevotella. Interestingly, after the end of probiotic administration Bacteroides, Barnesiella, Butyricicomonas, Clostridium, Haemophilus, Oscillibacter, Salmonella, Streptococcus, Subdoligranolum, and Veillonella were significantly reduced if compared to baseline samples.
L. kefiri LKF01 showed a strong ability to modulate the gut microbiota composition, leading to a significant reduction of several bacterial genera directly involved in the onset of pro-inflammatory response and gastrointestinal diseases.
已观察到益生菌对宿主健康有积极影响,但迄今为止,关于益生菌改变肠道微生物群组成能力的数据很少。
评估开菲尔乳杆菌LKF01 DSM32079(LKEF)定殖于健康受试者肠道环境并改变肠道微生物群组成的能力。
20名意大利健康志愿者被随机分为餐前组和餐后组。使用下一代测序技术(Ion Torrent个人基因组测序仪)检测肠道微生物群组成的变化。
在给予益生菌一个月后,所有志愿者的粪便中均检测到开菲尔乳杆菌,而在益生菌摄入结束一个月后,仅在3名餐前组受试者和2名餐后组受试者的粪便中检测到该菌。在口服益生菌一个月后,我们观察到嗜胆菌属、丁酸单胞菌属、黄酮分解菌属、颤杆菌属和普雷沃菌属减少。有趣的是,与基线样本相比,在益生菌给药结束后,拟杆菌属、巴恩斯氏菌属、丁酸单胞菌属、梭菌属、嗜血杆菌属、颤杆菌属、沙门氏菌属、链球菌属、副拟杆菌属和韦荣球菌属显著减少。
开菲尔乳杆菌LKF01显示出强大的调节肠道微生物群组成的能力,导致直接参与促炎反应和胃肠道疾病发生的几种细菌属显著减少。